Authors:
NISHIMURA A
HAMADA T
FUKUZAKI K
MIYAJIMA H
NAGATA R
KITO G
Citation: A. Nishimura et al., A NEW MODEL OF EXPERIMENTAL THROMBOEMBOLIC STROKE IN CYNOMOLGUS MONKEY, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 35169-35169
Authors:
KAMENOSONO T
NAGATOMO M
KITO T
NISHIMURA A
NAGATA R
KITO G
Citation: T. Kamenosono et al., CALCIUM-CHANNEL BLOCKERS IMPROVE THE PULMONARY-ARTERY VASOACTIVITY INMONOCROTALINE-INDUCED PULMONARY HYPERTENSIVE RATS, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 37172-37172
Citation: K. Sato et al., CHARACTERIZATION OF THE HIGH-SENSITIVITY OF RABBITS TO THE EFFECTS OFTCV-116, AN ANGIOTENSIN-II RECEPTOR ANTAGONIST, Fundamental and applied toxicology, 35(1), 1997, pp. 49-54
Citation: G. Kito et al., GENERAL PHARMACOLOGICAL PROPERTIES OF THE NEW ANGIOTENSIN-II RECEPTORANTAGONIST (+ -)-1-(CYCLOHEXYLOXYCARBONYLOXY) ETHYL 2-ETHOXY-1-[[2'-(1H-TETRAZOL-5-YL)BIPHENYL-4-YL] METHYL]-1H-BENZIMIDAZOLE-7-CARBOXYLATE.2. EFFECT ON CARDIOVASCULAR-SYSTEM AND RENAL FUNCTIONS/, Arzneimittel-Forschung, 46(7), 1996, pp. 681-686
Citation: G. Kito et al., GENERAL PHARMACOLOGICAL PROPERTIES OF THE NEW ANGIOTENSIN-II RECEPTORANTAGONIST (+ -)-1-(CYCLOHEXYLOXYCARBONYLOXY)ETHYL IPHENYL-4-YL]METHYL]1H-BENZIMIDAZOLE-7-CARBOXYLATE .1. EFFECTS ON CENTRAL-NERVOUS-SYSTEMAND OTHER PROPERTIES/, Arzneimittel-Forschung, 46(6), 1996, pp. 572-579